Welcome
prof. dr hab. n. med. Krzysztof Narkiewicz,
prof. Michel Burnier
5 min
08:35 – 09:50
Session 1. From biomarkers to clinical decisions — what really changes practice?
Chairs:
prof. dr hab. n. med. Andrzej Januszewicz,
prof. Alexandre Persu
75 min
08:35 - 08:50
Why do we need biomarkers — what do they add beyond conventional risk factors?
Carmine Zoccali
08:50 - 09:05
Different biomarkers, different questions
Francesca Mallamaci
09:05 - 09:20
From association to clinical utility — how should a new biomarker be validated?
prof. Christian Delles
09:20 - 09:35
When should a biomarker change treatment?
09:35 - 09:50
Discussion
09:50 – 10:10
Coffee break
20 min
10:10 – 12:10
Session 2. Hypertension in 2027: promises and disappointments in biomarkers, risk stratification and treatment targets
120 min
10:10 - 10:25
Homocysteine and B vitamins — old story, new evidence?
10:25 - 10:40
Inflammation and vascular dysfunction in hypertension — does hsCRP add value?
Daniela Carnevale
10:40 - 10:55
hs-Troponin and NT-proBNP — ready for risk stratification in hypertension?
prof. Gianfranco Parati
10:55 - 11:10
MicroRNAs — still promising or a missed opportunity?
11:10 - 11:25
Renin and aldosterone — can we use them to guide treatment?
11:25 - 11:40
Sympathetic activation — can we identify and treat the phenotype?
Stefano Masi
11:40 - 12:10
Discussion
12:30 – 14:00
Lunch
90 min
14:00 – 16:00
Session 3. Biomarkers in CKD — from progression to nephroprotective treatment
Chairs:
Liffert Vogt,
prof. Michel Burnier
120 min
14:00 - 14:15
New blood and urine biomarkers — do they improve risk prediction?
14:15 - 14:30
Tubular biomarkers — can they improve assessment of kidney injury and progression?
. Marius Miglinas
14:30 - 14:45
Albuminuria and eGFR slope — still the benchmarks?
Alberto Ortiz
14:45 - 15:00
Afamin — promising biomarker or another association?
15:00 - 15:15
pre-CKD (hrCKD) — new clinical entity in nephrology defined by biomarkers
prof. dr hab. n. med. Marcin Adamczak
15:15 - 15:30
From risk prediction to treatment selection — can biomarkers guide nephroprotection?
prof. dr hab. n. med. Andrzej Więcek
15:30 - 16:00
Discussion
16:00 – 16:20
Coffee break
20 min
16:25 – 17:35
Session 4. Heart Failure: from biomarkers to precision therapy and proactive care
Chairs:
prof. Gianfranco Parati,
Piotr Ponikowski
70 min
16:25 - 16:32
From molecular signatures to treatable endotypes: can multi-omics guide heart failure therapy?
16:32 - 16:44
Precision decongestion: urine sodium and beyond
dr hab. n. med., prof. UMW Jan Biegus
16:44 - 16:56
From blood tests to biosensors: towards real-time monitoring in heart failure
16:56 - 17:08
From multi-modal monitoring to supported self-management: can we prevent worsening heart failure?
17:08 - 17:20
Biomarker-guided precision medicine in heart failure: promise or clinical reality?
prof. dr hab. n. med. Ewa Jankowska
17:20 - 17:35
Panel discussion: from biomarker signals to clinical decisions — what is ready for practice?
Gdańsk, Poland | 22–24 April 2027
09:00 – 10:15
Session 5. Beyond blood biomarkers — digital phenotyping and imaging
75 min
09:00 - 09:15
Digital biomarkers in peripheral artery disease — ready for clinical use?
09:15 - 09:30
Renal MRI biomarkers — from tissue characterization to clinical decisions
09:30 - 09:45
Imaging biomarkers for Kidney Function and Disease: MRI and beyond
dr Anna Caroli
09:45 - 10:00
Cardiac CT and MRI biomarkers — what changes clinical management?
10:00 - 10:15
Discussion
10:15 – 10:35
Coffee break
20 min
10:35 – 11:50
Session 6. The future of biomarkers — what comes next?
Chairs:
dr Jan Danser,
prof. dr hab. n. med. Krzysztof Narkiewicz
75 min
10:35 - 10:50
From biomarkers to physiology — what can we learn from the kidney?
10:50 - 11:05
Will genetic biomarkers change clinical practice?
Olle Melander
11:05 - 11:20
Risk assessment in hypertension — where will biomarkers fit?
11:20 - 11:35
From cardiovascular risk prediction to treatment — which biomarkers will really matter in 2030?
11:35 - 11:50
Discussion
11:50 – 12:30
Discussion and closure of the meeting
Chairs:
prof. dr hab. n. med. Krzysztof Narkiewicz,
prof. Michel Burnier
The conferences website uses cookies. These are small text files sent by the www server and stored by the computer browser software. When the browser reconnects to the site, the site recognizes the type of device the user connects from.
Parameters allow to read the information contained in it, only to the server that created them. Cookies therefore facilitate the use of previously visited websites.